Inflammation and peritoneal dialysis

PKT Li, JKC Ng, CW Mcintyre - Seminars in Nephrology, 2017 - Elsevier
Inflammation is one of the well-recognized nontraditional risk factors that contributes to the
excessive cardiovascular mortality in peritoneal dialysis (PD) patients. Serum C-reactive …

Clinical studies of interventions to mitigate cardiovascular risk in peritoneal dialysis patients

D Jegatheesan, Y Cho, DW Johnson - Seminars in nephrology, 2018 - Elsevier
Cardiovascular disease (CVD) is highly prevalent in the peritoneal dialysis (PD) population,
affecting up to 60% of cohorts. CVD is the primary cause of death in up to 40% of PD …

Effects of ginger on serum glucose, advanced glycation end products, and inflammation in peritoneal dialysis patients

H Imani, H Tabibi, I Najafi, S Atabak, M Hedayati… - Nutrition, 2015 - Elsevier
Objective The aim of this study was to investigate the effects of ginger supplementation on
serum glucose, advanced glycation end products, oxidative stress, and systemic and …

Monocyte/lymphocyte ratio and cardiovascular disease mortality in peritoneal dialysis patients

Y Wen, X Zhan, N Wang, FF Peng… - Mediators of …, 2020 - Wiley Online Library
Objectives. The monocyte‐to‐lymphocyte ratio (MLR), as a new marker of the systemic
inflammatory response, is associated with cardiovascular disease (CVD) mortality in the …

Evaluating the effect of garlic extract on serum inflammatory markers of peritoneal dialysis patients: a randomized double-blind clinical trial study

E Zare, A Alirezaei, M Bakhtiyari, A Mansouri - BMC nephrology, 2019 - Springer
Background Garlic can be considered as a useful natural herb in inhibition of inflammation.
The aim of this study was to assess the effectiveness of garlic extract in lowering …

Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis–Associated Fibrosis

AC Raby, CS Colmont, A Kift-Morgan… - Journal of the …, 2017 - journals.lww.com
Peritoneal dialysis (PD) remains limited by dialysis failure due to peritoneal membrane
fibrosis driven by inflammation caused by infections or sterile cellular stress. Given the …

Paricalcitol attenuates TGF‐β1–induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 …

J Ko, HJ Kang, DA Kim, ES Ryu, M Yu, H Lee… - The FASEB …, 2019 - Wiley Online Library
Phenotype transition of mesothelial cells, such as epithelial‐to‐mesenchymal transition
(EMT), is one of the early mechanisms of peritoneal fibrosis, which is mediated by oxidative …

[HTML][HTML] Prevalence of dynapenic obesity and sarcopenic obesity and their associations with cardiovascular disease risk factors in peritoneal dialysis patients

H Tabibi, A As'habi, I Najafi… - Kidney research and …, 2018 - ncbi.nlm.nih.gov
Background Dynapenic obesity and sarcopenic obesity increase cardiovascular disease
(CVD) and mortality in nonuremic patients. The present study was designed to determine the …

[HTML][HTML] Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution–induced fibrosis

AC Raby, GT González-Mateo, A Williams, N Topley… - Kidney International, 2018 - Elsevier
Peritoneal membrane failure due to fibrosis limits the use of peritoneal dialysis (PD).
Peritoneal fibrosis may potentially be induced by sterile inflammation caused by ongoing …

[HTML][HTML] Association between dyslipidemia and peritoneal dialysis technique survival

N Stepanova, O Burdeyna - Open Access Macedonian Journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND: A large body of research has investigated the effects of pro-atherogenic
lipid profile on cardiovascular diseases (CVD) in peritoneal dialysis (PD) patients. However …